Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization

Riera-Montes, Margarita; Bollaerts, Kaatje; Heininger, Ulrich; Hens, Niel; Gabutti, Giovanni; Gil, Angel; Nozad, Bayad; Mirinaviciute, Grazina; Flem, Elmira; Souverain, Audrey; Verstraeten, Thomas; Hartwig, Susanne

doi:10.1186/s12879-017-2445-2

BMC Infectious Diseases

Table 4 Age-specific annual primary care incidence/100,000 of varicella in Europe before the introduction of universal childhood immunization programs

From: Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization

Country	Annual incidence /100,000 (min-max) per age group in years
Country	<5	5–9	10–14	15–19	20–39	40+
Austria^a	4773–5322	3623–5076	1610–3457	454–982	136–251	11–18
Belgium	4502-NA	1006-NA	190-NA	63-NA	49-NA	15-NA
Bulgaria^a	4301–4796	3895–5457	1610–3457	454–982	136–251	11–18
Croatia^a	4733–5278	3646–5109	1610–3457	454–982	136–251	11–18
Cyprus^a	5332–5946	3302–4626	346–742	141–304	86–158	30–49
Czech Rep.^a	4093–4565	4014–5624	1610-3457	454–982	136–251	11–18
Denmark^a	8480–9456	1490–2088	346–742	141–304	86–158	30–49
Estonia^a	4701–5242	3665–5134	1610–3457	454–982	136–251	11–18
Finland^a	5380-6000	3735-5232	51-109	25–54	24–45	19–31
France	10,694–13,069	3344–5917	368–1283	161–342	68–281	28–56
Germany^a	6312-7039	3032-4248	313-671	125–271	72–133	20–33
Greece^a	3746-4177	3211-4498	3562-7651	904–1955	216–398	9–15
Hungary^a	4649–5184	3695–5177	1610–3457	454–982	136–251	11–18
Iceland^a	6087-6788	3416-4786	0-0	0–0	0–0	0–0
Ireland^a	6349-7080	2768-3878	97-207	48–103	45–83	33–53
Italy	7476–7582	4548–5062	1052–2283	461–996	260–478	71–116
Latvia^a	4907–5472	3546–4968	1610–3457	454–982	136–251	11–18
Lithuania^a	5029–5608	3476–4870	1610–3457	454–982	136–251	11–18
Luxembourg^a	8350-9311	1416-1984	193-415	84–183	60–111	26–42
Malta^a	9547–10,646	876–1228	346–742	141–304	86–158	30–49
Netherlands	3032–5817	591–1535	52–180	32–92	23–50	12–23
Norway^a	7053–7865	2311–3238	346–742	141–304	86–158	30–49
Poland	3929-NA	4106-NA	923-NA	197-NA	77-NA	9-NA
Portugal^a	6742–7518	2490–3489	346–742	141–304	86–158	30–49
Romania	1100-NA	1450-NA	1000-NA	500-NA	89-NA	8-NA
Slovakia^a	4973-5545	3556-4981	1121-2407	366–791	138–255	17–27
Slovenia^a	6182-6894	2992-4192	348-748	145–314	92–170	32–52
Spain	8304-NA	3281-NA	747-NA	172–371	115–212	45–73
Sweden^a	7212–8042	2220–3110	346–742	141–304	86–158	30–49
Switzerland^a	3913-4364	5076-7112	94-202	45–97	38–69	22–37
UK	3838–4695	1562–3012	339–653	245–365	213–255	22–67

^acountries where primary care incidence was predicted NA: Not applicable

Back to article page

ISSN: 1471-2334

Contact us

Submission enquiries: bmcinfectiousdiseases@biomedcentral.com
General enquiries: ORSupport@springernature.com